| P2093 | author name string | Ahmet Gul | |
| | Zeki Kilicaslan | |
| | Tulin Cagatay | |
| | Ziya Gulbaran | |
| | Sule Sunmez | |
| | Penbe Cagatay | |
| | Bahar Artim | |
| | Munevver Aydin | |
| P2860 | cites work | Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent | Q28191546 |
| | Tumor necrosis factor alpha stimulates killing of Mycobacterium tuberculosis by human neutrophils | Q34128961 |
| | Physiology of cytokine pathways in rheumatoid arthritis | Q34222319 |
| | Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept | Q34515613 |
| | Tuberculosis following the use of etanercept, a tumor necrosis factor inhibitor | Q34649768 |
| | Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis | Q35555991 |
| | Infections and anti–tumor necrosis factor α therapy | Q35581950 |
| | Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists | Q35605635 |
| | The impact of new biologicals in the treatment of rheumatoid arthritis | Q35776802 |
| | Mantoux Test as a model for a secondary immune response in humans | Q36595911 |
| | Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor | Q36987279 |
| | Recombinant cytokines for controlling mycobacterial infections | Q40508105 |
| | The tuberculin skin test | Q40716380 |
| | The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection | Q43831403 |
| | Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report | Q45180236 |
| | Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. | Q51051059 |
| | Isoniazid intervention for latent tuberculosis among 86 patients with rheumatologic disease administered with anti-TNFalpha. | Q51476521 |
| | Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice. | Q52534755 |
| | Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection | Q56485907 |
| | Delayed cutaneous hypersensitivity in rheumatoid arthritis: the influence of nutrition and drug therapy | Q70584817 |
| | Pulmonary miliary tuberculosis in a patient with anti-TNF-alpha treatment | Q77844025 |
| | Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis | Q79253031 |
| | British Thoracic Society (BTS) recommendations for assessing risk and managing tuberculosis in patients due to start anti-TNF-{alpha} treatments | Q81235769 |
| | Diagnosis of latent tuberculosis infection: measure for measure | Q81823243 |
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | tuberculosis | Q12204 |
| P304 | page(s) | 1459-1463 | |
| P577 | publication date | 2009-10-21 | |
| P1433 | published in | Rheumatology International | Q15763689 |
| P1476 | title | Follow-up results of 702 patients receiving tumor necrosis factor-α antagonists and evaluation of risk of tuberculosis | |
| P478 | volume | 30 | |